E. C. Hsia

688 total citations · 1 hit paper
34 papers, 546 citations indexed

About

E. C. Hsia is a scholar working on Rheumatology, Hematology and Genetics. According to data from OpenAlex, E. C. Hsia has authored 34 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Rheumatology, 9 papers in Hematology and 7 papers in Genetics. Recurrent topics in E. C. Hsia's work include Rheumatoid Arthritis Research and Therapies (25 papers), Autoimmune and Inflammatory Disorders Research (9 papers) and Chronic Lymphocytic Leukemia Research (7 papers). E. C. Hsia is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (25 papers), Autoimmune and Inflammatory Disorders Research (9 papers) and Chronic Lymphocytic Leukemia Research (7 papers). E. C. Hsia collaborates with scholars based in United States, Switzerland and Canada. E. C. Hsia's co-authors include Mahboob U. Rahman, Edward Keystone, Stephen Hall, Mark C. Genovese, Sang‐Cheol Bae, William Palmer, J Pazdur, Maria Wiekowski, Pedro C. Miranda and Julie Zrubek and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Value in Health.

In The Last Decade

E. C. Hsia

28 papers receiving 518 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study

2008 432 citations Edward Keystone, Mark C. Genovese et al. Annals of the Rheumatic Diseases profile →

Peers

Countries citing papers authored by E. C. Hsia

Since Specialization

Citations

This map shows the geographic impact of E. C. Hsia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. C. Hsia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. C. Hsia more than expected).

Fields of papers citing papers by E. C. Hsia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. C. Hsia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. C. Hsia. The network helps show where E. C. Hsia may publish in the future.

Co-authorship network of co-authors of E. C. Hsia

This figure shows the co-authorship network connecting the top 25 collaborators of E. C. Hsia. A scholar is included among the top collaborators of E. C. Hsia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. C. Hsia. E. C. Hsia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of Golimumab, An Anti-Tnfα Monoclonal Antibody, On Health Related Quality of Life (Hrqol) And Work Productivity In Patients With Active Psoriatic Arthritis: 24-Week Results of The Phase Iii Go Vibrant Trial 2017 ·Value in Health ·M. Elaine Husni, Arthur Kavanaugh, (unknown), Chengcheng Han, Eric K. H. Chan, E. C. Hsia, (unknown), (unknown), D.D. Harrison, (unknown)	1
2	FRI0486 Intravenous golimumab in adult patients with active psoriatic arthritis: efficacy and safety through week 24 2017 ·Annals of the Rheumatic Diseases ·Arthur Kavanaugh, (unknown), D.D. Harrison, (unknown), (unknown), E. C. Hsia	1
3	THU0176 Golimumab 5-Year Safety: an Analysis of Pooled Data from the Long Term Extensions of Randomized, Double-Blind, Placebo-Controlled Studies in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis 2014 ·Annals of the Rheumatic Diseases ·(unknown), R Fleischmann, Edward Keystone, E. C. Hsia, Neil Goldstein, Benjamin Hsu, Yiying Zhou, Jürgen Braun, Arthur Kavanaugh	0
4	THU0513 Sustained Improvement in Health Related Quality of Life, Work Productivity, Employability, and Reduced Healthcare Resource Utilization of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Treated with Golimumab:5yr Results 2013 ·Annals of the Rheumatic Diseases ·(unknown), Arthur Kavanaugh, Mark C. Genovese, Atul Deodhar, Benjamin Hsu, E. C. Hsia	2
5	SAT0486 Early MRI Measures Independently Predict 1- and 2- Year X-Ray Progression: Results from a Large Clinical Trial 2013 ·Annals of the Rheumatic Diseases ·Joshua F. Baker, Mikkel Østergaard, Paul Emery, E. C. Hsia, Jiongdi Lu, Daniel L. Baker, Philip G. Conaghan	3
6	PREDICTORS OF RADIOGRAPHIC PROGRESSION IN METHOTREXATE-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS BASED ON ONE-YEAR RADIOGRAPHIC DATA FROM THE GO-BEFORE GOLIMUMAB CLINICAL TRIAL 2012 ·Data Archiving and Networked Services (DANS) ·Paul Emery, (unknown), Chenglong Han, (unknown), Philip G. Conaghan, W. Xu, E. C. Hsia	1
7	AB0460 Long-term remission with golimumab in active rheumatoid arthritis patients despite methotrexate through 2 years 2012 ·Annals of the Rheumatic Diseases ·Edward Keystone, Mark C. Genovese, Lars Klareskog, Stephen Xu, (unknown), E. C. Hsia	1
8	Magnetic resonance imaging assessments of patients with RA and their association with clinical and radiographic outcomes 2011 ·Annals of the Rheumatic Diseases ·Paul Emery, D. van der Heijde, Mikkel Østergaard, Philip G. Conaghan, Mark C. Genovese, E C Keystone, R Fleischmann, Wen‐Xiu Xu, (unknown), E. C. Hsia, Mahboob U. Rahman	1
9	Assessment of inflammation and damage by MRI in established RA patients with Methotrexate inadequate response receiving Golimumab: Results of the GO-FORWARD trial 2011 ·Annals of the Rheumatic Diseases ·Philip G. Conaghan, P. Emery, Mikkel Østergaard, Ed Keystone, Mark C. Genovese, Lars Klareskog, W. Xu, E. C. Hsia, Mahboob U. Rahman	2
10	Golimumab and Methotrexate combinatation therapy significantly improves synovitis, osteitis and bone erosion compared to Methotrexate alone - A magnetic resonance imaging study of Methotrexate-naïve rheumatoid arthritis patients 2011 ·Annals of the Rheumatic Diseases ·Mikkel Østergaard, Paul Emery, Philip G. Conaghan, R. Fleischmann, W. Xu, E. C. Hsia, Mahboob U. Rahman	2
11	GOLIMUMAB AND RADIOGRAPHIC PROGRESSION IN RHEUMATOID ARTHRITIS: RESULTS OF GO-BEFORE AND GO-FORWARD STUDIES 2011 ·Lara D. Veeken ·P. Emery, R. Fleischmann, Désirée van der Heijde, Edward Keystone, Mark C. Genovese, Philip G. Conaghan, E. C. Hsia, W. Xu, Anna Baratelle, Anna Beutler, Mahboob U. Rahman, (unknown)	1
12	Changes in patient characteristics in anti-tumour necrosis factor clinical trials for rheumatoid arthritis: results of an analysis of the literature over the past 16 years 2011 ·Annals of the Rheumatic Diseases ·Mahboob U. Rahman, Jacqueline Buchanan, Mittie K. Doyle, E. C. Hsia, (unknown), Shreekant Parasuraman, Daniel Aletaha, E. L. Matteson, Philip G. Conaghan, Edward Keystone, D. van der Heijde, Josef S Smolen	61
13	GOLIMUMAB SIGNIFICANTLY IMPROVES PHYSICAL FUNCTION AND FATIGUE IN RA PATIENTS PREVIOUSLY TREATED WITH ANTI-TNF AGENTS: RESULTS FROM THE GO-AFTER STUDY 2010 ·Lara D. Veeken ·(unknown), P Wordsworth, Mittie K. Doyle, J. Smolen, Jacqueline Buchanan, E. L. Matteson, E. C. Hsia, Robert Landewé, (unknown), (unknown), (unknown), (unknown)	3
14	GOLIMUMAB, A HUMAN TNF-ALPHA mu ONOCLONAL ANTIBODY, IN RHEUMATOID ARTHRITIS PATIENTS PREVIOUSLY TREATED WITH ANTI-TNF-ALPHA AGENTS (GO-AFTER STUDY) 2009 ·Lara D. Veeken ·P Wordsworth, Josef S Smolen, (unknown), Mittie K. Doyle, Robert Landewé, Eric L. Matteson, (unknown), E. C. Hsia, (unknown), (unknown)	1
15	Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study breakdown → 2008 ·Annals of the Rheumatic Diseases ·Edward Keystone, Mark C. Genovese, Lars Klareskog, E. C. Hsia, Stephen Hall, Pedro C. Miranda, J Pazdur, Sang‐Cheol Bae, William Palmer, Julie Zrubek, Maria Wiekowski, Sudha Visvanathan, Zhixian Wu, Mahboob U. Rahman	432
16	Golimumab, a new human Anti-TNF-alpha monoclonal antibody, administered subcutaneously everv 4 weeks in methotrexate-naive patients with active rheumatoid arthritis: A randomized, double-blind, placebo-controlled, GO-BEFORE study 2008 ·DIAL (Catholic University of Leuven) ·R Fleischmann, Patrick Durez, P. Emery, Larry W. Moreland, E. C. Hsia, Ingrid Strusberg, (unknown), Eric Amante, Melvin Churchill, (unknown), Bernardo A. Pons‐Estel, W. Xu, Mahboob U. Rahman	4
17	PMS43 GOLIMUMAB, A HUMAN ANTI-TNF-ALPHA MONOCLONAL ANTIBODY, SIGNIFICANTLY REDUCES TIME LOST FROM WORK FOR PATIENTS WITH RHEUMATOID ARTHRITIS: POOLED RESULTS FROMTHREE PHASE 3 STUDIES 2008 ·Value in Health ·Jacqueline Buchanan, P. Emery, (unknown), J. Smolen, (unknown), E. C. Hsia, (unknown), (unknown), Chengcheng Han, Shreekant Parasuraman	1
18	PMS65 GOLIMUMAB, A HUMAN ANTI-TNF-ALPHA MONOCLONAL ANTIBODY, SIGNIFICANTLY IMPROVES SELF-REPORTED PRODUCTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROMTHREE PHASE 3 STUDIES 2008 ·Value in Health ·(unknown), (unknown), M. C. Genovese, (unknown), E. C. Hsia, (unknown), (unknown), (unknown), (unknown)	1
19	Improvement in DAS28 response through one-year of golimumab treatment in patients with active RA despite treatment with methotrexate: A phase II, randomized, double blind, placebo controlled, dose ranging trial 2007 ·Annals of the Rheumatic Diseases ·Jonathan Kay, Patrick Durez, Eric L. Matteson, B. Dasgupta, Peter Nash, Stephen Hall, E. C. Hsia, (unknown), Jia Han, Mahboob U. Rahman	2
20	One-year results of golimumab compared with placebo in patients with active RA despite treatment with methotrexate: A phase II, randomized, double-blind, placebo-controlled, dose-ranging trial. 2006 ·Digital Access to Libraries ·Jonathan Kay, Patrick Durez, Eric L. Matteson, B. Dasgupta, Peter Nash, Stephen Hall, E. C. Hsia, (unknown), Jia Han, Mahboob U. Rahman	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact